These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2872058)

  • 1. The pharmacokinetics after intravenous and oral administration in man of the alpha 2-adrenoreceptor antagonist idazoxan (RX781094).
    Muir NC; Lloyd-Jones JG; Nichols JD; Clifford JM
    Eur J Clin Pharmacol; 1986; 29(6):743-5. PubMed ID: 2872058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of ex vivo platelet aggregation to confirm the in vivo alpha 2-adrenoreceptor antagonist effect of idazoxan in man.
    Muir NC; Doxey JC; Havler ME; Clifford JM
    J Pharmacol Methods; 1987 Sep; 18(2):95-102. PubMed ID: 2887703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic profile of idazoxan in the beagle dog.
    Vallès J; Pruñonosa J; Menargues A; Nomen M; Obach R
    J Pharm Pharmacol; 1989 Jun; 41(6):384-7. PubMed ID: 2570833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding characteristics of the selective alpha 2-adrenoceptor antagonist [3H]idazoxan to rat olfactory cortex membranes.
    McLaughlin NJ; Collins GG
    Eur J Pharmacol; 1986 Feb; 121(1):91-6. PubMed ID: 2869959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics and metabolism of idazoxan in the rat.
    Lewis CJ; Havler ME; Humphrey MJ; Lloyd-Jones JG; McCleavy MA; Muir NC; Waltham K
    Xenobiotica; 1988 May; 18(5):519-32. PubMed ID: 2899932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High affinity binding of idazoxan to a non-catecholaminergic binding site in the central nervous system: description of a putative idazoxan-receptor.
    Wikberg JE
    Pharmacol Toxicol; 1989 Jan; 64(1):152-5. PubMed ID: 2569190
    [No Abstract]   [Full Text] [Related]  

  • 7. Different alpha 2-adrenoceptor densities in the circular and longitudinal layers of human near-term myometrium as revealed by [3H]-idazoxan binding studies.
    Breuiller M; Rouot B; Leroy MJ; Blot P; Ferré F
    Gynecol Obstet Invest; 1988; 26(1):14-20. PubMed ID: 2901998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative autoradiographic localization of alpha 2-antagonist binding sites in rat brain using [3H]idazoxan.
    Brüning G; Kaulen P; Baumgarten HG
    Neurosci Lett; 1987 Dec; 83(3):333-7. PubMed ID: 2894626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for non-adrenergic binding sites for [3H]idazoxan in the smooth muscle of rabbit urethra.
    Yablonsky F; Riffaud JP; Lacolle JY; Dausse JP
    Eur J Pharmacol; 1988 Sep; 154(2):209-12. PubMed ID: 2906613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]idazoxan binding at non-alpha 2-adrenoceptors in rabbit adipocyte membranes.
    Langin D; Lafontan M
    Eur J Pharmacol; 1989 Jan; 159(2):199-203. PubMed ID: 2565242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral pre and postjunctional alpha 2-adrenoceptors in man: studies with RX781094, a selective alpha 2 antagonist.
    Elliott HL; Jones CR; Reid JL
    J Hypertens Suppl; 1983 Dec; 1(2):109-11. PubMed ID: 6152738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiloride interacts with [3H]idazoxan and [3H]rauwolscine binding sites in rabbit urethra.
    Yablonsky F; Dausse JP
    Eur J Pharmacol; 1989 May; 164(1):167-70. PubMed ID: 2568937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High affinity binding of 3H rauwolscine and 3H RX781094 to alpha 2 adrenergic receptors and non-stereoselective sites in human and rabbit brain cortex membranes.
    Convents A; Convents D; De Backer JP; De Keyser J; Vauquelin G
    Biochem Pharmacol; 1989 Feb; 38(3):455-63. PubMed ID: 2563652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]idazoxan binding to the ovine myometrium. Binding characteristics and changes due to steroid hormones.
    Vass-Lopez A; Garcia-Villar R; Lafontan M; Toutain PL
    J Pharmacol Exp Ther; 1990 May; 253(2):819-24. PubMed ID: 1971023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacokinetic-pharmacodynamic linking model for the alpha 2-adrenergic antagonism of idazoxan on clonidine-induced mydriasis in the rat.
    Valles J; Obach R; Menargues A; Pruñonosa J; Jane F
    J Pharm Pharmacol; 1995 Feb; 47(2):157-61. PubMed ID: 7602472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the regulation of [3H]idazoxan and [3H]yohimbine binding sites in the rabbit.
    Yakubu MA; Deighton NM; Hamilton CA; Reid JL
    Eur J Pharmacol; 1990 Feb; 176(3):305-11. PubMed ID: 1970303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site.
    Michel MC; Brodde OE; Schnepel B; Behrendt J; Tschada R; Motulsky HJ; Insel PA
    Mol Pharmacol; 1989 Mar; 35(3):324-30. PubMed ID: 2564631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RX781094, a new potent alpha 2 adrenoceptor antagonist. In vivo and in vitro studies in the rabbit.
    Hannah JA; Hamilton CA; Reid JL
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Apr; 322(3):221-7. PubMed ID: 6135163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buccal delivery of an alpha 2-adrenergic receptor antagonist, atipamezole, in humans.
    Huupponen R; Karhuvaara S; Anttila M; Vuorilehto L; Scheinin H
    Clin Pharmacol Ther; 1995 Nov; 58(5):506-11. PubMed ID: 7586944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral idazoxan bioavailability in rat. Relevance of intestinal and hepatic first-pass effect.
    Vallès J; Pruñonosa J; Menargues A; Nomen M; Obach R
    Drug Metab Dispos; 1989; 17(6):673-6. PubMed ID: 2575506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.